Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosome-mediated delivery of SCD-1 siRNA promoted the death of anaplastic thyroid carcinoma cells via regulating ROS level
Menghan Wang, Y Ye, Meng-jie zhang, et al.
Clinical & Translational Oncology (2021) Vol. 24, Iss. 2, pp. 288-296
Closed Access | Times Cited: 18

Showing 18 citing articles:

Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Ying Zhang, Qiqi Liu, Xinmeng Zhang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 197
Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective
Jieyu Liu, Yinan Bai, Yinggang Li, et al.
EBioMedicine (2024) Vol. 107, pp. 105301-105301
Open Access | Times Cited: 82
Therapeutic potential of RNA-enriched extracellular vesicles: The next generation in RNA delivery via biogenic nanoparticles
Muskan Muskan, Pevindu Abeysinghe, Riccardo Cecchin, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2939-2949
Closed Access | Times Cited: 39
Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges
Philemon Ubanako, Sheefa Mirza, Paul Ruff, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 7
Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy
Gang� Li, Xin Li, Iqbal Mahmud, et al.
JCI Insight (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 24
Unlocking the potential of exosomes in cancer research: A paradigm shift in diagnosis, treatment, and prevention
Saloomeh Khoushab, Mina Hobabi Aghmiuni, Negin Esfandiari, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155214-155214
Closed Access | Times Cited: 4
CTC, ctDNA, and Exosome in Thyroid Cancers: A Review
Wenwen Wang, Zhiyao Zheng, Jianyong Lei
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13767-13767
Open Access | Times Cited: 11
Reprogramming of Thyroid Cancer Metabolism: from Mechanism to Therapeutic Strategy
Yajuan Wan, Guoqing Li, Gaoyuan Cui, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Navigating thyroid cancer complexity: the emerging role of EV-derived non-coding RNAs
Meng Jia, Jiawen Liang, Lu Gao, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Recent Trends in the Use of Small Extracellular Vesicles as Optimal Drug Delivery Vehicles in Oncology
Sarwareddy Kartik Kumar, Sasidhar Venkata Manda
Molecular Pharmaceutics (2023) Vol. 20, Iss. 8, pp. 3829-3842
Closed Access | Times Cited: 9
Revealing Cellular Heterogeneity and Key Regulatory Factors of Triple-Negative Breast Cancer through Single-Cell RNA Sequencing
Hu Zhang, Yanan Sun, Xinna Du
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 3
Role of Extracellular Vesicles in Thyroid Physiology and Diseases: Implications for Diagnosis and Treatment
Ophélie Delcorte, Jonathan Degosserie, Christophe E. Pierreux
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2585-2585
Open Access | Times Cited: 7
Exosomal noncoding RNAs: decoding their role in thyroid cancer progression
Weiming Sun, Chenjun Jiang, Qianqian Liu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Research progress of exosomes as drug carriers in cancer and inflammation
Qixiang Feng, Yu Zhang, Yuelin Fang, et al.
Journal of drug targeting (2022) Vol. 31, Iss. 4, pp. 335-353
Closed Access | Times Cited: 6
STRA6 Promotes Thyroid Carcinoma Progression via Activation of the ILK/AKT/mTOR Axis in Cells and Female Nude Mice
Weiman He, Zhen Cheng, Zijun Huo, et al.
Endocrinology (2023) Vol. 164, Iss. 3
Open Access | Times Cited: 3
Nanotechnological Advancements for the Theranostic Intervention in Anaplastic Thyroid Cancer: Current Perspectives and Future Direction
Sai Swetha Uppalapati, Lahanya Guha, Hemant Kumar, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 3, pp. 245-270
Closed Access | Times Cited: 3
Exploring exosomes: novel diagnostic and therapeutic frontiers in thyroid cancer
Sicheng Zhang, Yan Yang, Dianri Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Estudios lipidómicos en macrófagos. Regulación de los niveles lipídicos por lipinas y su impacto en la biología del macrófago y en procesos inflamatorios
Álvaro Garrido Jiménez
(2023)
Open Access
Page 1

Scroll to top